HGH HOLDINGS LTD. (5GZ) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of HGH HOLDINGS LTD. S$0.02, price S$0.02, upside +53.8%, quality 55 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch HGH HOLDINGS LTD. for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.
How to read this chart
60‑month range 0.0090 SGD – 0.0320 SGD · fair‑value band 0.0198 SGD – 0.0262 SGD · the 0.0160 SGD price screens below the 0.0246 SGD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 27, 2026.
Follow HGH HOLDINGS in your weekly email
Every Wednesday you see whether HGH HOLDINGS is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
HGH Holdings Ltd., an investment holding company, provides leasing and services in Singapore and Malaysia. The company operates through four segments: Leasing and Service Income; Manufacturing of Precast Concrete Products; Supply and Manufacturing of Ready-Mix Concrete Products; and Provision of Underground Cable Installation and Road Reinstatement.
Show more
HGH Holdings Ltd., an investment holding company, provides leasing and services in Singapore and Malaysia. The company operates through four segments: Leasing and Service Income; Manufacturing of Precast Concrete Products; Supply and Manufacturing of Ready-Mix Concrete Products; and Provision of Underground Cable Installation and Road Reinstatement. It also provides general warehousing and logistics services; supplies precast concrete products; and industrial and office spaces for engineering, manufacturing, and industrial training and workers' dormitory facilities. In addition, the company offers structural and non-structural precast concrete products for civil and construction works, as well as for civil engineering contractors. Further, it provides underground cable installation comprising the installation of power cables, auxiliary cables, and other accessories under the ground; ready-mix concrete; and road reinstatement, including the backfilling and reinstatement of road surfaces, as well as business and management consultancy and other business support services. HGH Holdings Ltd. was founded in 1995 and is based in Singapore.
Stock analysis
HGH HOLDINGS LTD. (5GZ) currently trades at 0.0160 SGD, while our model-based Fair Value estimate is 0.0246 SGD, implying the stock looks roughly 35.0% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 0.1500 SGD per share, and 15 of the 15 models we run sit above the 0.0160 SGD price.
Bear case: the Asset-Based group reads lowest at 0.0200 SGD, and 0 of the 15 models stay below the price. Evidence for this calculation is low.
Scenario range: 0.0198 SGD (bear) to 0.0262 SGD (bull), the price of 0.0160 SGD sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 55/100 (solid quality), in the Industrials sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
HGH HOLDINGS LTD. reported revenue of 54.6M SGD in FY2025 versus 20.1M SGD in FY2021, a compound +28.5%/yr. Reported net income was 5.2M SGD in FY2025.
Key figures
Market cap 28.5M SGD (≈ $22.2M) · P/S ratio 0.49 · Net margin 9.6% · Return on equity 10.7% · Return on assets (EBIT) −0.2% · Operating margin 12.8% · Revenue (TTM) 54.6M SGD · Revenue growth (YoY) +138%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 43% below its 52-week high and 7% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Industrials peers we cover trades at −38% fair-value upside, at 54%, 5GZ screens cheaper than that median.
Fair Value models
Bear 0.0198 SGDFair Value 0.0246 SGDBull 0.0262 SGD
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.58/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+156.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+36.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+36.1%
Start year 2020 (pandemic). Over 10 years: +13.4% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.8%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−15.1% (2020) → 11.8% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no profitable base year
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Electrical Equipment & Parts · 532 stocks
Beats the industry median on 10/10 measures
Overall it ranks above its industry peers.
Valuation
Quality Score55 · Above median
Fair Value upside+53.8% · Top 25%
Profitability
Return on equity (TTM)10.7% · Above median
Return on assets4.7% · Above median
Net margin (TTM)9.6% · Above median
Operating margin (TTM)12.8% · Top 25%
Growth and dividend
Revenue growth138.2% · Top 25%
Valuation Multiplesvs Electrical Equipment & Parts median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is HGH HOLDINGS LTD. (5GZ) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of 0.0246 SGD versus a price of 0.0160 SGD, about +54% upside (undervalued).
What is the fair value of 5GZ?
Our model-based fair value for HGH HOLDINGS LTD. is 0.0246 SGD (as of Sep 27, 2026), built from audited fundamentals. The current price: 0.0160 SGD.
What is the quality score of 5GZ?
HGH HOLDINGS LTD. has a Quality Score of 55/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for HGH HOLDINGS LTD. (5GZ)?
Our model-based price target is the fair value of 0.0246 SGD (as of Sep 27, 2026) from 15 valuation models. Cautious scenario 0.0198 SGD, optimistic scenario 0.0262 SGD. It is a calculation from audited fundamentals, not an analyst target.
What is the HGH HOLDINGS LTD. stock forecast for 2026?
Our models put fair value at 0.0246 SGD, about +54% upside versus a price of 0.0160 SGD (undervalued). Cautious scenario 0.0198 SGD, optimistic scenario 0.0262 SGD. The calculation is refreshed regularly with new filings.
What is the revenue of HGH HOLDINGS LTD. (5GZ)?
HGH HOLDINGS LTD. reported trailing-twelve-month revenue of about 54.6M SGD (latest available figure, as of Sep 27, 2026).
What is the intrinsic value of HGH HOLDINGS LTD. (5GZ)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For HGH HOLDINGS LTD. it is 0.0246 SGD per share (as of Sep 27, 2026), against a price of 0.0160 SGD. It is the blended result of 15 valuation models (cash flow, earnings, asset, dividend).
Is HGH HOLDINGS LTD. stock overvalued or undervalued in 2026?
As of Sep 27, 2026, 5GZ trades below its calculated fair value: price 0.0160 SGD, fair value 0.0246 SGD, a gap of about +54% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 5GZ?
No. The price is what the market pays today (0.0160 SGD); the fair value is what the company's own numbers justify (0.0246 SGD). For HGH HOLDINGS LTD. the two are 0.0086 SGD per share apart. That gap is exactly why we show both numbers side by side.
How much is HGH HOLDINGS LTD. worth?
The market values HGH HOLDINGS LTD. at about 28.5M SGD (market capitalisation, as of Sep 27, 2026). Per share that is 0.0160 SGD; our models calculate a fair value of 0.0246 SGD per share.
What do the bullish and bearish scenarios say about 5GZ?
Our models span a range for HGH HOLDINGS LTD.: cautious scenario 0.0198 SGD, base 0.0246 SGD, optimistic 0.0262 SGD per share (as of Sep 27, 2026, price 0.0160 SGD). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of HGH HOLDINGS LTD. (5GZ)?
Balance-sheet figures for HGH HOLDINGS LTD. (as of Sep 27, 2026): return on equity 10.7%. They feed the Quality Score of 55/100, which measures business quality independently of the share price.
How far is 5GZ from its 52-week high?
HGH HOLDINGS LTD. trades at 0.0160 SGD, about 43% below its 52-week high of 0.0280 SGD and 7% above the low of 0.0150 SGD (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of 0.0246 SGD is for.
Which stocks are comparable to HGH HOLDINGS LTD.?
From the same area (Industrials) we also value Contemporary Amperex Technology Co, ABB Ltd, Delta Electronics (Thailand) Public Company, Vertiv Holdings, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is HGH HOLDINGS LTD. stock attractive at the current price?
The data as of Sep 27, 2026: price 0.0160 SGD, calculated fair value 0.0246 SGD (+54%), Quality Score 55/100, from 15 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 5GZ calculated?
We run HGH HOLDINGS LTD. through 15 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 0.0246 SGD, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. HGH HOLDINGS LTD. currently trades 35 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of HGH HOLDINGS LTD. (5GZ)?
The closing price on Oct 1, 2026 was 0.0160 SGD. Our model-based fair value is 0.0246 SGD, about +54% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with HGH HOLDINGS LTD. right now?
The price is below even our cautious bear case (0.0198 SGD). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (55/100) at a price below fair value, the discount is the argument here, not the business quality.
Key figures of HGH HOLDINGS LTD.
How large is the market capitalisation of HGH HOLDINGS LTD. (5GZ)?
The market capitalisation of HGH HOLDINGS LTD. is 28.5M SGD (≈ $22.2M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of HGH HOLDINGS LTD. (5GZ)?
The price-to-sales ratio of HGH HOLDINGS LTD. is 0.49 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of HGH HOLDINGS LTD. (5GZ)?
The net margin of HGH HOLDINGS LTD. is 9.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of HGH HOLDINGS LTD. (5GZ)?
The return on equity (ROE) of HGH HOLDINGS LTD. is 10.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of HGH HOLDINGS LTD. (5GZ)?
On an EBIT basis the return on assets of HGH HOLDINGS LTD. is −0.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of HGH HOLDINGS LTD. (5GZ)?
The operating margin of HGH HOLDINGS LTD. is 12.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at HGH HOLDINGS LTD. (5GZ)?
Revenue at HGH HOLDINGS LTD. is growing +138% versus a year earlier (3y avg +36.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at HGH HOLDINGS LTD. (5GZ)?
Earnings per share at HGH HOLDINGS LTD. are growing +335% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does HGH HOLDINGS LTD. (5GZ) generate?
The free cash flow of HGH HOLDINGS LTD. is −3.1M SGD (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed
Watch HGH HOLDINGS LTD. in the live analysis
One click puts HGH HOLDINGS LTD. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
